PUBLICATIONS

Parker, N.R., Hudson, A.L.*, Khong, P., Parkinson, J.F., Dwight, T., Ikin, R.J., Zhu, Y., Cheng, Z.J., Vafaee, F., Chen, J., Wheeler, H.R. and Howell, V.M.
Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma. Sci Rep, 6: 22477. (2016)[*Joint 1st author ]

“Divergent clonal selection dominates medulloblastoma at recurrence.”
Nature, Volume:529,Pages:351–357
Date published: (21 January 2016) DOI: doi:10.1038/nature16478

Gzell C, Wheeler H, Guo L, Kastelan M, Back M.
Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.
J Neurooncol. 2014 Aug;119(1):187-96.

Back M, Back E, Wheeler H.
Cognitive Deficits in Primary Brain Tumours: A Framework for Management and Rehabilitation.
Journal of Cancer Therapy. 2014 Jan 5(1) 74-81.

GONZALVO A, BIGGS M, HARRIS M, McKENZIE C:
“Primary Non-Hodgkins Lymphoma of Radial Nerve”
In print. Accepted by Neurosurgery. For publication Sept 2010

Jonathon F. Parkinson, Helen R. Wheeler, Adele Clarkson, Catriona A. McKenzie, Michael T. Biggs, Nicholas S. Little,
Raymond J. Cook, Marinella Messina, Bruce G. Robinson & Kerrie L. McDonald.
Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma.
J Neurooncol (2008) 87:71–78

YUILE P, DENT O, COOK R, BIGGS M, LITTLE N:
“Survival of Glioblastoma patients related to presenting symptoms, brain site and treatment variables”
Journal of Clinical Neuroscience. Vol. 13, issue 7, Aug 2006 pp 747-751

SMITH S, SIMPSON J, BREWER J, SEKHON L, BIGGS M, COOK R, LITTLE N:
“The Presence of Necrosis and/or Microvascular Proliferation Does Not Influence Survival of Patients with Anaplastic Oligodendroglial Tumours: Review of 98 Patients”
J. Neurooncology

MATAR E, COOK R, BIGGS M, LITTLE N, WHEELER H, ROBINSON B, McDONALD K:
“Post-contrast enhancement status as a clinical indicator of prognosis in Patients with anaplastic astrocytoma”
In print. Accepted by Journal of Clinical Neuroscience

PARKINSON JF, AFAGHI V, PAYNE CA, BUCKLAND ME, BREWER JM, BIGGS MT, LITTLE NS, WHEELER HR, COOK RJ, McDONALD KL:
“Single Centre Experience in Oligodendroglioma over 20 years – impact Of molecular and clinical factors on outcome”
Submitted to Journal of Clinical Neuroscience

Back M, Gzell CE, Kastelan M, Guo L, Wheeler HR.
Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.
Neurooncol Pract. 2015 Mar;2(1):48-53.

Gzell C, Wheeler H, Guo L, Kastelan M, Back M.
Employment following chemoradiotherapy in glioblastoma: a prospective case series.
J Cancer Surviv. 2014 Mar;8(1):108-13.

Back M, Clifford S, Wheeler H, Guo L, Eade T.
Dosimetric improvements utilizing Intensity Modulated Radiation Therapy for Patients with Glioblastoma Multiforme.
Journal of Cancer Therapy. 2013 Dec 4(11a) 18-24.

FOWLER A, COOK R, BIGGS M, LITTLE N, ASSAAD N, McDONALD K:
“Survival of Patients following neurosurgical treatment of colorectal Adenocarcinoma metastasis in the Northern Sydney-Central Coast area”
Journal of Clinical Neuroscience 15 (2008), 998-1004

Jonathon F. Parkinson, Helen T. Wheeler, Kerrie L. McDonald.
Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma.
Journal of Clinical Neuroscience 15 (2008) 1–8

Kerrie L. McDonald, PhD, Maree G. O’Sullivan, MSc, Jonathon F. Parkinson, MBBS, Janet M. Shaw, BSc, Cathy A. Payne, BSc, Janice M. Brewer, MBBS, Lawrence Young, BSc, Dianne J. Reader, BSc, Helen T. Wheeler, MBBS, FRACP, Raymond J. Cook, MBBS, FRACS, Michael T. Biggs, MBBS, FRACS, Nicholas S. Little, MBBS, FRACS, Charlie Teo, MBBS, FRACS, Glenn Stone, PhD, and Bruce G. Robinson, MD, MSc, FRACP.
IQGAP1 and IGFBP2: Valuable Biomarkers for Determining Prognosis in Glioma Patients.
J Neuropathol Exp Neurol Vol. 66, No. 5 Copyright Ó 2007 by the American Association of Neuropathologists, Inc. May 2007 pp. 405Y417

YUILE P, DENT O, COOK R, BIGGS M, LITTLE N:
“Survival of Glioblastoma patients related to presenting symptoms, brain site and treatment variables”
Abstract published in: Radiotherapy & Oncology. Vol 64 (Supplement 1)
S296, Sept. 2002

McDONALD KL, McDONNELL J, MUNTONI A, HENSON J, HEGI M, WHEELER H, COOK R, BIGGS M, LITTLE N, ROBINSON BG, REDDEL RR, ROYDS JA:
“The presence of Alternative Lengthening of Telomere (ALT) mechanism in Patients with glioblastoma multiforme identifies a less aggressive tumour Type and longer survival.
In Print. Accepted by JNEN

GONZALVO A, FOWLER A, BIGGS M, COOK R, LITTLE N, McDONALD K:
“Schwannomatosis, Sporadic Schwannomatosis and Familial Schwannomatosis: A Surgical Series with Long Term Follow up”
In print. Accepted for publication by Neurosurgery

FOWLER A, THOMPSON D, MESSINA M, MALEKI S, GILES K, LEEDMAN P, WHEELER H, BIGGS M, COOK R, LITTLE N, ASSAAD N, ROBINSON B, McDONALD K:
“Micro RNA 124a regulates glioblastoma invasion by IQGAP1 down Regulation”
Submitted to Molecular Cancer